Ocular Therapeutix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. 

CEO
Pravin U. Dugel
CEOPravin U. Dugel
Employees
267
Employees267
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2006
Founded2006
Employees
267
Employees267

OCUL Key Statistics

Market cap
908.24M
Market cap908.24M
Price-Earnings ratio
-4.67
Price-Earnings ratio-4.67
Dividend yield
—
Dividend yield—
Average volume
4.00M
Average volume4.00M
High today
—
High today—
Low today
—
Low today—
Open price
$5.06
Open price$5.06
Volume
0.00
Volume0.00
52 Week high
$11.31
52 Week high$11.31
52 Week low
$2.00
52 Week low$2.00

OCUL News

Yahoo Finance 2d
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Yahoo Finance

Ocular Therapeutix, Inc. First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings con...

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Yahoo Finance

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.